Copenhagen Pharma Consulting ApS

CVR number: 41537388
Rødtjørnevej 8, 2720 Vanløse
holtenand@fastmail.fm

Income statement (kDKK)

202120222023
Fiscal period length121212
Net sales
Gross profit3 291.271 304.772 931.27
Employee benefit expenses-2 128.71-1 345.03-2 498.33
EBIT1 162.56-40.26432.94
Other financial income10.175.664.17
Other financial expenses-13.59-12.90-5.13
Pre-tax profit1 159.13-47.50431.98
Income taxes- 255.189.70-96.29
Net earnings903.96-37.80335.69

Assets (kDKK)

202120222023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current trade debtors124.97219.25
Current amounts owed by group member comp.951.00790.29999.99
Current other receivables4.94
Current deferred tax assets9.70
Short term receivables total1 080.911 019.24999.99
Cash and bank deposits254.58226.341 351.68
Cash and cash equivalents254.58226.341 351.68
Balance sheet total (assets)1 335.491 245.592 351.67

Equity and liabilities (kDKK)

202120222023
Share capital40.0040.0040.00
Shares repurchased117.80
Retained earnings903.96748.36
Profit of the financial year903.96-37.80335.69
Shareholders equity total943.96906.161 241.85
Non-current liabilities total
Current trade creditors14.4517.0019.00
Current owed to participating1.881.881.88
Short-term deferred tax liabilities255.1896.29
Other non-interest bearing current liabilities120.03320.55992.65
Current liabilities total391.53339.431 109.82
Balance sheet total (liabilities)1 335.491 245.592 351.67
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.